Earnings summaries and quarterly performance for Emerald Holding.
Executive leadership at Emerald Holding.
Board of directors at Emerald Holding.
Research analysts who have asked questions during Emerald Holding earnings calls.
Recent press releases and 8-K filings for EEX.
Emerald announces Q3 2025 results and updates full-year guidance
EEX
Earnings
Guidance Update
Share Buyback
- Emerald reported Q3 2025 revenue of $77.5 million and Adjusted EBITDA (ex-insurance) of $12.8 million, resulting in a diluted loss per share of $(0.07). Year-to-date 2025, the company achieved 13.3% year-over-year revenue growth and 32.4% year-over-year Adjusted EBITDA growth.
- The company updated its Full Year 2025 guidance, raising the revenue range to $460-$465 million and Adjusted EBITDA to $122.5-$127.5 million, primarily reflecting the acquisition of Generis.
- Emerald repurchased 116,094 shares for $0.5 million in Q3 2025 and announced an extension and expansion of its share repurchase program, allowing for $25.0 million in repurchases through December 31, 2026. A dividend of $0.015 per share was also declared for the quarter ending December 31, 2025.
Oct 31, 2025, 12:30 PM
Emerald Holding Inc. Reports Q3 2025 Results, Updates Full-Year Guidance, and Details Acquisitions
EEX
Earnings
Guidance Update
M&A
- Emerald Holding Inc. (EEX) reported Q3 2025 revenue of $77.5 million and adjusted EBITDA of $12.8 million. Year-to-date, total revenue reached $330.7 million and adjusted EBITDA was $90.8 million.
- The company updated its full-year 2025 guidance, raising and narrowing the range to $460 million to $465 million for revenue and $122.5 million to $127.5 million for adjusted EBITDA, reflecting the Generis acquisition and increased visibility.
- Q3 organic revenue declined 6.8% year over year, primarily due to construction at the Las Vegas Convention Center and tariff headwinds, which had an approximately 6% negative impact on organic revenue for a large event.
- Emerald completed the acquisition of Generis in Q3 2025, which is expected to contribute an additional $10 million in revenue in 2026 that was not recognized in 2025 due to timing.
- The Board approved an extension and expansion of the share repurchase authorization for up to $25 million through December 31, 2026, with $20.3 million remaining under the prior authorization at the end of Q3. A quarterly dividend of $0.015 per share was also declared.
Oct 31, 2025, 12:30 PM
Emerald Holdings Reports Q3 2025 Results, Raises Full-Year Guidance, and Expands Share Repurchase Program
EEX
Earnings
Guidance Update
M&A
- Emerald Holdings reported Q3 2025 revenue of $77.5 million and adjusted EBITDA of $12.8 million, representing a 2.4% increase year-over-year for EBITDA. Year-to-date, total revenue grew 13.3% to $330.7 million and adjusted EBITDA increased 32.4% to $90.8 million.
- The company raised and narrowed its full-year 2025 guidance for revenue to $460 million-$465 million and adjusted EBITDA to $122.5 million-$127.5 million, reflecting the Generis acquisition and increased visibility.
- The Generis acquisition closed in Q3 2025, contributing no revenue in the quarter but absorbing $1 million in SG&A costs, and is anticipated to add $10 million in incremental revenue in 2026.
- In Q3, Emerald repurchased approximately 116,000 shares at an average price of $4.87 per share, and the board approved an additional $25 million for share repurchases through December 31, 2026, while also declaring a quarterly dividend of $0.015 per share.
Oct 31, 2025, 12:30 PM
Emerald Holding Inc. Reports Q3 2025 Results and Updates Full-Year Guidance
EEX
Earnings
Guidance Update
M&A
- Emerald Holding Inc. reported Q3 2025 revenue of $77.5 million and adjusted EBITDA of $12.8 million. Year-to-date, total revenue increased by 13.3% to $330.7 million, and adjusted EBITDA rose by 32.4% to $90.8 million.
- The company increased and narrowed its full-year 2025 guidance for revenue to $460 million to $465 million and adjusted EBITDA to $122.5 million to $127.5 million, reflecting the Generis acquisition and year-to-date performance.
- In Q3 2025, Emerald repurchased approximately 116,000 shares at an average price of $4.87 per share, and the Board approved an extension of the share repurchase authorization for up to $25 million through December 31, 2026. A quarterly dividend of $0.015 per share was also declared.
- Q3 organic revenue was negatively impacted by 6.8% year-over-year, primarily due to ongoing construction at the Las Vegas Convention Center and tariff headwinds affecting a large event.
- Strategic initiatives include the acquisition of Generis, a leader in peer-to-peer executive events, and the launch of an AI-powered event agent to enhance customer experience.
Oct 31, 2025, 12:30 PM
Emerald Holding, Inc. Reports Q3 2025 Financial Results and Updates Full-Year Outlook
EEX
Earnings
Guidance Update
Dividends
- Emerald Holding, Inc. reported Q3 2025 revenues of $77.5 million, an increase of 6.7% over the prior year period, and year-to-date 2025 revenues of $330.7 million, up 13.3%.
- Adjusted EBITDA for Q3 2025 was $12.8 million, a 2.4% increase, and year-to-date Adjusted EBITDA was $90.8 million, a 32.4% increase. The company reported a net loss of $14.4 million for Q3 2025 and a net loss of $0.5 million year-to-date 2025.
- The company updated its Full Year 2025 guidance for revenue to $460-$465 million and Adjusted EBITDA to $122.5-$127.5 million, reflecting the Generis acquisition.
- The Board of Directors declared a dividend of $0.015 per share for the quarter ending December 31, 2025, and the company repurchased 116,094 shares for $0.5 million in Q3 2025.
Oct 31, 2025, 10:26 AM
Emerald Holding Reports Q3 2025 Financial Results and Updates Full-Year Outlook
EEX
Earnings
Guidance Update
Share Buyback
- Emerald Holding reported revenues of $77.5 million for Q3 2025, an increase of 6.7% over the prior year, with a net loss of $14.4 million. Adjusted EBITDA for Q3 2025 was $12.8 million, a 2.4% increase. For the nine months ended September 30, 2025, revenues increased 13.3% to $330.7 million, and Adjusted EBITDA rose 32.4% to $90.8 million.
- The company updated its Full Year 2025 guidance, raising the revenue range to $460–$465 million and Adjusted EBITDA to $122.5–$127.5 million, primarily due to the Generis acquisition.
- Emerald's Board of Directors extended and expanded its share repurchase program to allow for up to $25.0 million in repurchases through December 31, 2026. The company repurchased 116,094 shares for $0.5 million in Q3 2025 and 3.8 million shares for $16.2 million year-to-date 2025. A dividend of $0.015 per share was declared for Q4 2025.
Oct 31, 2025, 10:25 AM
Quarterly earnings call transcripts for Emerald Holding.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
Let Fintool AI Agent track Emerald Holding's earnings for you
Get instant analysis when filings drop